NEXTGENPCR: 30 cycli, 3 temperatures, less than 2 minutes

MBS Selects AMPLITECH To Launch NEXTGENPCR in France and Switzerland.

Strong demand predicted across all life science markets

Dutch biotechnology company Molecular Biology Systems(MBS) today announced it will launch its revolutionary NEXTGENPCR thermal cycler through AMPLITECH, an independent commercial organization offering innovative solutions to the public and private in vitro diagnostic testing market, including cytogenetics, molecular genetics, and pathology labs, in France, Belgium, Luxembourg, and Switzerland.


Read the whole article: MBS Selects CAMLAB To Launch NEXTGENPCR In UK At Lab Innovations

Comments are closed here.